Author

M. R. Marien

Observed names: M MARIEN, M Marien, M R Marien, M. MARIEN, M. Marien, M. R. MARIEN, M.R. Marien, MR Marien

Observed institutions: University of California, Santa Barbara, GlaxoSmithKline (Italy), Servier (France), Pierre Fabre (France)

OpenAlex ID: A5111363889

Levomilnacipran (F2695), a norepinephrine-preferring SNRI: Profile in vitro and in models of depression and anxiety

2013 · A.L. Auclair, J.C. Martel, et al. · Neuropharmacology · 267

Effects of locus coeruleus lesions on parkinsonian signs, striatal dopamine and substantia nigra cell loss after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in monkeys: A possible role for the locus coeruleus in the progression of Parkinson's disease

1991 · M. Mavridis, A.-D. Degryse, et al. · Neuroscience · 214

Picomolar affinity of 125I-SCH 23982 for D1 receptors in brain demonstrated with digital subtraction autoradiography

1987 · CA Altar, MR Marien · Journal of Neuroscience · 103

PDF

Quantitative autoradiography of brain binding sites for the vesicular acetylcholine transport blocker 2-(4-phenylpiperidino)cyclohexanol (AH5183).

1987 · M R Marien, S M Parsons, et al. · Proceedings of the National Academy of Sciences · 65

Effects of the α2-adrenoreceptor antagonist dexefaroxan on neurogenesis in the olfactory bulb of the adult rat in vivo: selective protection against neuronal death

2003 · S Bauer, E Moyse, et al. · Neuroscience · 61

Intracerebral dialysis: Direct evidence for the utility of 3-MT measurements as an index of dopamine release

1987 · P.L. Wood, H.S. Kim, et al. · Life Sciences · 56

α2-Adrenoceptor modulation of cortical acetylcholine release in vivo

1999 · S Tellez, F Colpaert, et al. · Neuroscience · 48

Neuroprotective Effects of the α2-Adrenoceptor Antagonists, (+)-Efaroxan and (±)-Idazoxan, against Quinolinic Acid-Induced Lesions of the Rat Striatum

1998 · J.-C. Martel, P. Chopin, et al. · Experimental Neurology · 40

Dimerization of sumatriptan as an efficient way to design a potent, centrally and orally active 5-HT1B agonist

1998 · Michel Perez, Petrus J. Pauwels, et al. · Bioorganic & Medicinal Chemistry Letters · 38

Inhibition of [3H]‐(+)‐MK 801 binding to rat brain sections by CPP and 7‐chlorokynurenic acid: an autoradiographic analysis

1993 · S. Tacconi, E. Ratti, et al. · British Journal of Pharmacology · 24

In vivo upregulation of endogenous NGF in the rat brain by the alpha2-adrenoreceptor antagonist dexefaroxan: potential role in the protection of the basalocortical cholinergic system during neurodegeneration

2004 · Thomas Debeir, M. Marien, et al. · Experimental Neurology · 20

Modulation of mesolimbic dopaminergic projections by beta-endorphin in the rat

1989 · S. Iyengar, Helen S. Kim, et al. · Neuropharmacology · 20

Constant infusion of [13C6]glucose: Simultaneous measurement of turnover of GABA and glutamate in defined regions of the brain of individual animals

1988 · P WOOD, H KIM, et al. · Neuropharmacology · 20

Poly(ADP‐Ribose) Polymerase (PARP) Revisited: A New Role for an Old Enzyme: PARP Involvement in Neurodegeneration and PARP Inhibitors as Possible Neuroprotective Agents

1997 · C. COSI, H. SUZUKI, et al. · Annals of the New York Academy of Sciences · 17

Functional Neuropharmacology of Compounds Acting at 5-HT1B/D Receptors

2000 · M. Briley, P. Chopin, et al. · Handbook of experimental pharmacology · 16

Protective effects of the α2-adrenoceptor antagonist, dexefaroxan, against degeneration of the basalocortical cholinergic system induced by cortical devascularization in the adult rat

2002 · T Debeir, M Marien, et al. · Neuroscience · 13

Stability of dopamine in an in vitro incubation system using Medium 199

1984 · M. R. Marien, S. H. Shin, et al. · Canadian Journal of Physiology and Pharmacology · 12

Effects of kainic acid lesioning on poly(ADP-ribose) polymerase (PARP) activity in the rat striatum in vivo

2000 · C. Cosi, E. Cavalieri, et al. · Amino Acids · 10

Injections of deuterated tryptamine into the nucleus accumbens of the rat: Effects on locomotor activity and monoamine metabolism

1987 · M.R. Marien, R. Gerber, et al. · Neuropharmacology · 10

Protective effect of the α2-adrenoceptor antagonist, dexefaroxan, against spatial memory deficit induced by cortical devascularization in the adult rat

2003 · P. Chopin, T. Debeir, et al. · Experimental Neurology · 9

Arylpiperazide derivatives of phenylpiperazines as a new class of potent and selective 5-HT1B receptor antagonists

1997 · C. Jorand-Lebrun, P.J. Pauwels, et al. · Bioorganic & Medicinal Chemistry Letters · 7

Drug treatments to reduce excitotoxicity in vivo : a potential for α 2 -adrenoceptor antagonists?

2000 · J.-C. Martel, P. Chopin, et al. · Amino Acids · 4

Central Cholecystokinin Receptors: Opportunity for Drug Discovery

1992 · G. Gaviraghi, A. Feriani, et al. · Pharmacochemistry library · 4

Effects of milnacipran and venlafaxine on extracellular levels of 5-HT and noradrenaline in guinea pig hypothalamus

1998 · C. Moret, M. Marien · European Psychiatry · 1

PDF

Effects of Noradrenaline Depletion by Dsp4 on Nigrostriatal and Mesolimbic Dopamine Release in Vivo; a Microdialysis Study

1992 · A. J. Lategan, M. R. Marien, et al. · Clinical Neuropharmacology · 1

Works count: 30

Citation count: 1,080

H-index: 15

I10-index: 19